RE:RE:RE:RE:TimeAny Buyout offer before FDA Approval will be an attempt at a steal for 1/2 billion USD or less.
Management will counter with an advisary to Shareholders not to take any action, as it severely undervalues us by being only 20-30% of what we will be worth upon FDA Approval in February or before.
The Seeking Alpha article posted here previously several times gives what they feel is fair value in differing scenarios and time periods, with $15 USD ($4.5 billion) being the highest, by about 2018-19 after Approval worldwide and running to peak sales.
Have a exit strategy and be happy with the 20/20 hindsight kicking your buutt as you left so much on the table....Not many of us peons will get out at the peak. Bank on it.
JMHO and Good Luck everyone ! Even paranoid Dimsum.